Compare Chipotle Mexican Grill, Inc. (CMG) vs Neurocrine Biosciences Inc (NBIX) Price & Performance

Chipotle Mexican Grill, Inc.Trade

Neurocrine Biosciences IncTrade

Price performance (Past 24H)

Key statistics

Chipotle Mexican Grill, Inc. vs Neurocrine Biosciences Inc — how do they compare? Chipotle Mexican Grill, Inc. trades at $32.75 (market cap $40.49B), while Neurocrine Biosciences Inc trades at $158.92 (market cap $16.46B). The key difference: Chipotle Mexican Grill, Inc. is far larger — about 2.5× Neurocrine Biosciences Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Chipotle Mexican Grill, Inc. nearer its low. Which is the better fit depends on your goals.

	CMG	NBIX
Market Cap	$40.49B	$16.46B
Sector	Consumer Cyclical	Health
52-Week High	$44.04	$185.50
52-Week Low	$28.17	$123.10
Enterprise Value	$45.24B	$16.48B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CMG

Chipotle shares drop over 12% amid margin pressure and cautious outlook despite growth plans.24/7 Wall Street · 1 day agoBullish Chipotle IQ trivia returns with $1M in prizes, new card game, and free burritos for a year sweepstakesPRNewsWire · 1 day agoBullish Michael Burry doubts Berkshire Hathaway's new leadership under Greg Abel, Meta faces $1.4T US penalties, Taylor Farms recalls jalapeño products.Seeking Alpha · 2 days agoBearish View details →

NBIX

INGREZZA shows significant quality of life and movement improvements in tardive dyskinesia patients after 24 weeks.PRNewsWire · 4 hours agoBullish View details →

About Chipotle Mexican Grill, Inc.

Chipotle Mexican Grill is the largest fast-casual chain restaurant in the United States, with systemwide sales of $7.5 billion in 2021. The Mexican concept is entirely company-owned, with a footprint of more than 3,000 stores, heavily indexed to the United States (though the firm maintains a small presence in Canada, the U.K., France, and Germany). Chipotle sells burritos, burrito bowls, tacos, quesadillas, and beverages, with a selling proposition built around competitive prices, high-quality food sourcing, speed of service, and convenience. The company generates its revenue entirely from restaurant sales and delivery fees.

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.